ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.125
-0.10%
US Dollar vs AUD
1.50145
0.31%
Bitcoin
66,306.54
1.64%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ContextLogic Inc (LOGC)

  7. ContextLogic Inc (LOGC) News

LOGC

ContextLogic (LOGC)

ContextLogic Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LOGC
DateTimeSourceHeadlineSymbolCompany
11/02/202308:40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LOGCContextLogic Inc
30/11/202208:07Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:LOGCContextLogic Inc
21/11/202222:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LOGCContextLogic Inc
17/11/202208:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
17/11/202208:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
17/11/202208:04Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
17/11/202208:04Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:LOGCContextLogic Inc
17/11/202208:04Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:LOGCContextLogic Inc
17/11/202201:56Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:LOGCContextLogic Inc
17/11/202200:30Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:LOGCContextLogic Inc
17/11/202200:21Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:LOGCContextLogic Inc
15/11/202200:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LOGCContextLogic Inc
15/11/202200:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
15/11/202200:00PR Newswire (US)LogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesNASDAQ:LOGCContextLogic Inc
20/10/202223:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LOGCContextLogic Inc
19/10/202207:14Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:LOGCContextLogic Inc
19/10/202207:04Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:LOGCContextLogic Inc
14/10/202207:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LOGCContextLogic Inc
08/10/202207:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
04/10/202207:47Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:LOGCContextLogic Inc
04/10/202202:20Dow Jones NewsLogicBio Therapeutics Shares Soar on Takeover by AstraZenecaNASDAQ:LOGCContextLogic Inc
04/10/202201:50TipRanksAnalysts Offer Insights on Healthcare Companies: Clene (CLNN) and Logicbio Therapeutics (LOGC)NASDAQ:LOGCContextLogic Inc
03/10/202223:19TipRanksAstraZeneca to Buy LogicBio Therapeutics for $2.07 Per ShareNASDAQ:LOGCContextLogic Inc
03/10/202222:57Dow Jones NewsAstraZeneca to Buy LogicBio Therapeutics for $68 MillionNASDAQ:LOGCContextLogic Inc
03/10/202222:15Business WireAlexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineNASDAQ:LOGCContextLogic Inc
03/10/202222:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
03/10/202222:00PR Newswire (US)Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineNASDAQ:LOGCContextLogic Inc
24/09/202207:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
21/09/202222:30PR Newswire (US)LogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONENASDAQ:LOGCContextLogic Inc
21/09/202207:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LOGCContextLogic Inc
 Showing the most relevant articles for your search:NASDAQ:LOGC

Your Recent History

BTRX
SKLUSD
SKALE
LSE
BR12
Lloyds Bcm 26
ASX
BRX
Belararox
EU
3589T
3589T
BMF
PTXUSDC
PTXUSDC
EU
GSSXL
Delta Lloyd Asset Manage...
LSE
JFT
IDCM
REPUSDT
Augur Reputation v2
LSE
RR.B
Rolls-royce
COIN
CCTCBTC
LSE
FB54
Bank Mont.28
LSE
0LQO
Vmware
KUCN
AGIXBTC
SingularityNET Token
USOTC
AIOSF
Atresmedia Corporation D... (PK)
ASE
G090312F1E
Hellenic Republic
BIT
UC6Z5L
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved